Attached files

file filename
XML - IDEA: XBRL DOCUMENT - CytoCore IncR22.htm
EXCEL - IDEA: XBRL DOCUMENT - CytoCore IncFinancial_Report.xls
XML - IDEA: XBRL DOCUMENT - CytoCore IncR8.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR9.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR2.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR31.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR33.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR35.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR28.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR32.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR37.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR30.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR29.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR25.htm
EX-32.1 - EXHIBIT 32.1 - CytoCore Incv326519_ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - CytoCore Incv326519_ex31-1.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR5.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR1.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR4.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR3.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR7.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR24.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR19.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR20.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR27.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR21.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR36.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR12.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR13.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR14.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR16.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR17.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR10.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR34.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR18.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR38.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR23.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR15.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR26.htm
10-Q - FORM 10-Q - CytoCore Incv326519_10q.htm
XML - IDEA: XBRL DOCUMENT - CytoCore IncR11.htm
v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Operating Activities:    
Net loss $ (1,009) $ (1,550)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 171 351
Common stock issued for compensation 30 39
Benefit from derivative liability 0 (30)
Interest expense imputed on related party advances 170 124
Common stock issued for services 91 93
Gain on settlement of trade indebtedness 490 (15)
Changes in assets and liabilities:    
Accounts receivable (162) 4
Prepaid expenses and other current assets (1) 15
Accounts payable (997) (109)
Accrued expenses 609 548
Net cash used in operating activities (608) (530)
Investing activities:    
Net cash used in investing activities 0 0
Financing activities:    
Proceeds from related parties 524 555
Proceeds from sale of machinery 70 0
Repayment of notes 0 (37)
Net cash provided by financing activities 594 518
Net increase (decrease) in cash and cash equivalents (14) (12)
Cash and cash equivalents at the beginning of period 15 [1] 13
Cash and cash equivalents at end of period 0 1
Non-cash transactions during the period for:    
Conversion of debt and accrued interest to common stock 0 59
Reclassification of liability (relating to variable conversion feature) to additional paid-in-capital upon conversion of debt 0 55
Reclassification of excess share derivative liability to additional paid-in- Capital 0 14
Write off of certain payables no longer valid due to the statue of limitations 490 0
Settlement of other payables $ 0 $ 15
[1] Derived from audited information